tiprankstipranks
Trending News
More News >
Innate Pharma (IPHA)
NASDAQ:IPHA

Compare Innate Pharma (IPHA) vs. Competitors

Compare
130 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma
$1.31
$126.93M
-1.54
-32.82%
1 Buy
0 Hold
0 Sell
Moderate Buy
SELLAS Life Sciences Group
$4.11
$705.09M
-6.42
358.33%
1 Buy
0 Hold
0 Sell
Moderate Buy
Sangamo Biosciences
$0.36
$133.81M
-1.47
-57.45%
1 Buy
1 Hold
0 Sell
Moderate Buy
Elicio Therapeutics
$11.68
$214.87M
-3.95
46.55%
3 Buy
0 Hold
0 Sell
Strong Buy
Vor Biopharma
$13.00
$539.76M
-21.36%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHA
Innate Pharma
1.31
-0.69
-34.34%
SLS
SELLAS Life Sciences Group
4.95
3.74
309.09%
SGMO
Sangamo Biosciences
0.36
-0.48
-57.09%
GNFT
ELTX
Elicio Therapeutics
11.68
3.56
43.84%
VOR
Vor Biopharma
13.00
-4.04
-23.71%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts